Ingredion's T&HS Segment Posts Ninth Straight Quarter of Volume Growth

Zacks Investment Research··US·Read original
3▲3 ▼0Impact / 5
Summary · why it matters

Ingredion Incorporated's Texture & Healthful Solutions segment extended its growth streak, with net sales rising 5% year over year to $627 million and net sales volumes up 7% in the second quarter of 2026, marking the ninth consecutive quarter of volume growth. Segment operating income increased 5% to $117 million, the second-highest quarterly operating income in T&HS history, while operating margin improved to 18.7% from 18.5% a year ago. The company said the volume strength was not driven by customer restocking or demand pulled forward ahead of pricing actions, and that solutions continued to grow faster than the rest of the business. For 2026, Ingredion expects T&HS net sales to rise in the mid-single digits and operating income to increase in the mid-to-high single digits, though higher tapioca costs and an unfavorable price mix could limit margin improvement. Separately, International Flavors & Fragrances reported Taste sales growth of 4% to $688 million and Health & Biosciences growth of 5% to $601 million in the second quarter of 2026, with EBITDA up 6% in both segments, while Archer-Daniels-Midland reported Nutrition operating profit of $172 million, up 51%, and Human Nutrition operating profit up 51% to $139 million.

Impact on assets 3

Synthetic Biology (non-pharma)▲ · 3 stocks
Ingredion Incorporated
INGR
▲ PositiveCapitalDemandrelevance

T&HS operating income rose 5% to $117 million with margin improving to 18.7%, and 2026 guidance calls for mid-single-digit sales and mid-to-high single-digit operating income growth.

Archer-Daniels-Midland Company
ADM
▲ PositiveCapitalrelevance

ADM reported Nutrition operating profit up 51% and Human Nutrition operating profit up 51% to $139 million in Q2 2026.

International Flavors & Fragrances Inc
IFF
▲ PositiveCapitalrelevance

IFF reported Taste sales growth of 4% to $688 million and Health & Biosciences growth of 5% to $601 million, with EBITDA up 6% in both segments.

© 2026 MarketIVNews